[Clinical practice guideline for the evaluation and management of upper gastrointestinal bleeding in EsSalud: 2024 Update].

Q4 Medicine

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2025-04-01

Luis Cervera-Caballero, Ana Brañez-Condorena, Alejandro Piscoya, Nelly Vásquez-Valverde, Ericson Arcana-López, Javier Contreras-Turin, Daniel Vargas-Blácido, Alvaro Taype-Rondan, Joan Caballero-Luna, Fabiola Huaroto-Ramírez

{"title":"[Clinical practice guideline for the evaluation and management of upper gastrointestinal bleeding in EsSalud: 2024 Update].","authors":"Luis Cervera-Caballero, Ana Brañez-Condorena, Alejandro Piscoya, Nelly Vásquez-Valverde, Ericson Arcana-López, Javier Contreras-Turin, Daniel Vargas-Blácido, Alvaro Taype-Rondan, Joan Caballero-Luna, Fabiola Huaroto-Ramírez","doi":"","DOIUrl":null,"url":null,"abstract":"Introduction: This article summarizes the clinical practice guideline (CPG) for the evaluation and management of upper gastrointestinal bleeding (UGIB) in the Social Security of Peru (EsSalud).Methods: A guideline development group comprising medical specialists and methodologists, formulated clinical questions addressed by CPG. Systematic evidence searches were conducted for each question during 2024. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology was used to assess the certainty of the evidence and formulate the recommendations. The CPG was approved through Resolution No. 000022-IETSI-ESSALUD-2024.Results: This CPG addressed 11 clinical questions, divided into four topics: risk assessment, initial management, variceal UGIB management, and non-variceal UGIB management. Based on these questions, 11 recommendations (7 strong recommendations and 4 weak recommendations), 24 good clinical practices, and 2 flowcharts were formulated. For the 2024 guideline update, no new evidence was found to change the recommendations' direction or strength.Conclusion: This article summarizes the methodology and evidence-based conclusions from the CPG for evaluating and managing UGIB in EsSalud.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 2","pages":"202-212"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: This article summarizes the clinical practice guideline (CPG) for the evaluation and management of upper gastrointestinal bleeding (UGIB) in the Social Security of Peru (EsSalud).

Methods: A guideline development group comprising medical specialists and methodologists, formulated clinical questions addressed by CPG. Systematic evidence searches were conducted for each question during 2024. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology was used to assess the certainty of the evidence and formulate the recommendations. The CPG was approved through Resolution No. 000022-IETSI-ESSALUD-2024.

Results: This CPG addressed 11 clinical questions, divided into four topics: risk assessment, initial management, variceal UGIB management, and non-variceal UGIB management. Based on these questions, 11 recommendations (7 strong recommendations and 4 weak recommendations), 24 good clinical practices, and 2 flowcharts were formulated. For the 2024 guideline update, no new evidence was found to change the recommendations' direction or strength.

Conclusion: This article summarizes the methodology and evidence-based conclusions from the CPG for evaluating and managing UGIB in EsSalud.

本刊更多论文

[EsSalud上消化道出血评估与处理临床实践指南：2024年更新]。

简介：本文总结了秘鲁社会保险（EsSalud）评估和管理上消化道出血（UGIB）的临床实践指南（CPG）。方法：一个由医学专家和方法学家组成的指南制定小组，制定由CPG解决的临床问题。在2024年对每个问题进行了系统的证据检索。建议分级评估、发展和评价（GRADE）方法用于评估证据的确定性并制定建议。CPG通过第000022-IETSI-ESSALUD-2024号决议批准成立。结果：本CPG涉及11个临床问题，分为4个主题：风险评估、初始管理、静脉曲张UGIB管理和非静脉曲张UGIB管理。根据这些问题，制定了11条建议（7条强建议、4条弱建议）、24条临床良好规范和2个流程图。对于2024年的指南更新，没有发现新的证据来改变建议的方向或强度。结论：本文总结了CPG评估和管理esalud UGIB的方法和循证结论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Medicine-Medicine (all)

CiteScore

0.40

自引率

0.00%

发文量

期刊介绍： La REVISTA DE GASTROENTEROLOGíA DEL PERÚ, es la publicación oficial de la Sociedad de Gastroenterología del Perú que publica artículos originales, artículos de revisión, reporte de casos, cartas e información general de la especialidad; dirigido a los profesionales de la salud con especial interés en la gastroenterología. La Revista de Gastroenterología del Perú es una publicación de periodicidad trimestral y tiene como objetivo la publicación de artículos científicos inéditos en el campo de la gastroenterología, proporcionando información actualizada y relevante de la especialidad y áreas afines. La Revista de Gastroenterología del Perú publica artículos en dos idiomas, español e inglés, a texto completo en la versión impresa yelectrónica. Los artículos científicos son sometidos a revisores o árbitros nacionales e internacionales, especialistas que opinan bajo la modalidad de doble ciego y de manera anónima sobre la calidad y validez de los mismos. El número de revisores depende del tipo de artículo, dos revisores como mínimo para artículos originales y uno como mínimo para otros tipos de artículos.